The impact of COVID-19 pandemic on fragility hip fracture management and mortality rate
Completed
- Conditions
- Mortality rate in osteoporotic hip fracture between COVID-19 pandemic and pre-pandemic periodFragility hip fracture, osteoporotic fracture, COVID-19, mortality
- Registration Number
- TCTR20221028002
- Lead Sponsor
- Maharat Nakhon Ratchasima Hospital
- Brief Summary
Proportion of patients with insufficient and deficient vitamin D were significantly higher in the pandemic group (46.1% vs 63.09%). Time to surgery and length of hospital stay were significantly longer in the pandemic period. The mortality was higher but not significantly different in the pandemic period with adjusted hazard ratio of 1.06 (95% CI 0.74, 1.51).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 859
Inclusion Criteria
Hip fracture from low energy trauma
Exclusion Criteria
Pathological fracture
Fail to adhere follow-up plan
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality rate and 1-year mortality rate from admission to 12 months after discharge Dead cases divided by total cases
- Secondary Outcome Measures
Name Time Method Serum vitamin D level During admission Serum vitamin D level from blood test